N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide
C20H13ClF2N4O3S — CID 58316939
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide
N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide (PubChem CID 58316939) has the molecular formula C20H13ClF2N4O3S and a molecular weight of 462.87 g/mol. Its IUPAC name is N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide.
Molecular Properties
| Compound Name | N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide |
|---|---|
| PubChem CID | 58316939 |
| Molecular Formula | C20H13ClF2N4O3S |
| Molecular Weight | 462.87 g/mol |
| Exact Mass | 462.04 |
| IUPAC Name | N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-methylbenzenesulfonamide |
| SMILES | Cc1ccc(S(=O)(=O)Nc2ccc(F)c(C(=O)c3c[nH]c4ncnc(Cl)c34)c2F)cc1 |
| InChI | InChI=1S/C20H13ClF2N4O3S/c1-10-2-4-11(5-3-10)31(29,30)27-14-7-6-13(22)16(17(14)23)18(28)12-8-24-20-15(12)19(21)25-9-26-20/h2-9,27H,1H3,(H,24,25,26) |
| InChIKey | XPPWWMGNCWESCZ-UHFFFAOYSA-N |
| XLogP | 4.23 |
| TPSA | 104.81 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.87 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58316939 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.